Ad
related to: ARWR
Search results
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) Could Bring Massive Returns? – Marketing Sentinel
Marketing Sentinel· 3 hours agoIn today’s recent session, 0.56 million shares of the Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) have been traded, and its beta is 0.94. Most recently the company’s share ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript May 9, 2024 Arrowhead...
Arrowhead Pharmaceuticals director sells shares worth over $41k By Investing.com
Investing.com· 7 days agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Director Victoria Vakiener has recently sold shares of...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $50.80 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering ...
Arrowhead Pharmaceuticals Reports Substantial Fiscal Q2 Loss, Di
Guru Focus· 3 days agoOn May 9, 2024, Arrowhead Pharmaceuticals Inc (ARWR, Financial) disclosed its financial outcomes for the second quarter of fiscal year 2024, which concluded on March 31, 2024 ...
Arrowhead Research: Fiscal Q2 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 4 days agoPASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Arrowhead Research Corp. (ARWR) on Thursday reported a fiscal second-quarter loss of $125.3 million, after reporting a profit ...
Arrowhead Pharmaceuticals Inc. [ARWR] Director makes an insider sale of 1,799 shares worth 41,935. –...
Knox Daily· 4 days agoAs published in their initiating research note from BofA Securities on December 04, 2023, Arrowhead Pharmaceuticals Inc. [ARWR] has been a Buy and the price target has been ...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 6.5% on Disappointing Earnings
ETF DAILY NEWS· 2 days agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report)’s share price fell 6.5% during mid-day trading on Friday after the company announced weaker than expected quarterly ...
Arrowhead Pharmaceuticals Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 7 days agoAs a result of the transaction, Lu Hongbo now holds 33,680 shares, worth roughly $0.85 million. BofA Securities initiated its Arrowhead Pharmaceuticals Inc. [ARWR] rating ...
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day...
Benzinga· 3 days agoShares of Diodes Incorporated DIOD fell sharply during Friday's session after the company reported...
